Tristel PLC (TSTL) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to the Tristell PLC interim results investor presentation. Throughout this recorded presentation, investors will be in listen-only mode. Questions are encouraged and they can be submitted at any time using the Q&A tab situated on the right-hand corner of your screen. Simply type in your questions and press send. Before we begin, I would like to submit the following poll, and I would now like to hand you over to the management team of Tristell. Matt, Matt, good morning to you. Hi, good morning. Thank you for joining us today for Tricell's interim results, H1 financial year 2026. I'm joined today by Anna Russell, Tricell's CFO, and Yulia Shapanova, who's Tricell's executive director. I appreciate that Yulia may be a new name to some of the investors joining us today. So let me just give a brief background into her. She's been executive director at Tricell and president of our U.S. subsidiary. This year actually marks her 20th year with Tricell. So she's a very long serving member of the team. Julia has really been an instrumental part of the leadership team. She executed the scientific program with the FDA, securing our U.S. market entry, and really has been leading our commercial efforts with working on the launch of our two key products there, ultrasound and OPH. As we go through the presentation, Julia will be updating you all on the progress we're making in the U.S.A. So that being said, let me just also take a moment to acknowledge the announcement that was made earlier this year that I will be stepping down as chief executive at the end of the financial year. This was a deeply considered personal decision. Tricell is a business with exceptional people, a strong depth in its leadership and a very clear strategic outlook and trajectory. A l...